肾脏疾病中的肥胖悖论:如何与肥胖管理相协调
本文综述了晚期慢性肾脏病(CKD)中肥胖悖论现象,即肥胖是新发CKD的危险因素却在晚期CKD中带来生存优势,并与其他心血管风险反向流行病学现象并列。作者讨论了该悖论也见于心衰、慢阻肺、肝硬化、转移性癌及老年人等蛋白质能量消耗和炎症预测早死的群体,肌肉量较体脂带来更优生存,并提出时间错位假说及血流动力学稳定、脂蛋白防御、保护性细胞因子、脂肪毒素隔离和肌肉抗氧化等机制。
要点
- 肥胖是新发CKD的危险因素,但在晚期CKD中与生存优势相关,构成肥胖悖论。
- 肥胖悖论也见于心衰、慢阻肺、肝硬化、转移性癌及老年人等蛋白质能量消耗和炎症高发人群。
- 肌肉量较体脂带来更优生存,较大肌肉量和较高体脂均与这些患者长寿相关,而较瘦体型和体重减轻与较高死亡率相关。
核心结论
- 肥胖悖论与残余混杂的统计学谬误说法相反,数据一致性和其他因果线索提示其具有高度生物学合理性,研究其因果可能揭示改善CKD患者结局的重要病理生理机制。
研究设计与样本
- 本文为综述,检索范围原文未报告。
主要发现
- 肥胖是新发CKD的危险因素,但在晚期CKD中带来生存优势。
- 肥胖悖论也见于心衰、慢阻肺、肝硬化、转移性癌及老年人,这些人群中蛋白质能量消耗和炎症是早死的强预测因子。
- 较大肌肉量和较高体脂均与这些患者长寿相关,而较瘦体型和体重减轻与较高死亡率相关。
- 肌肉量似乎优于体脂,带来更大的生存获益。
- 肥胖悖论可能是竞争风险因素时间错位的结果,即过度营养作为长期杀手与营养不足作为短期杀手之间的错位。
关键数值与推荐
- 原文未报告具体阈值或数值标准。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文提到有人声称肥胖悖论是统计谬误和残余混杂的结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Obesity, a risk factor for de novo chronic kidney disease (CKD), confers survival advantages in advanced CKD. This so-called obesity paradox is the archetype of the reverse epidemiology of cardiovascular risks, in addition to the lipid, blood pressure, adiponectin, homocysteine, and uric acid paradoxes. These paradoxical phenomena are in sharp contradistinction to the known epidemiology of cardiovascular risks in the general population. In addition to advanced CKD, the obesity paradox has also been observed in heart failure, chronic obstructive lung disease, liver cirrhosis, and metastatic cancer, as well as in the elderly. These are populations in whom protein-energy wasting and inflammation are strong predictors of early death. Both larger muscle mass and higher body fat provide longevity in these patients, whereas thinner body habitus and weight loss are associated with higher mortality. Muscle mass appears to be superior to body fat in conferring an even greater survival. The obesity paradox may be the result of a time discrepancy between competing risk factors, i.e., overnutrition as the long-term killer versus undernutrition as the short-term killer. Hemodynamic stability of obesity, lipoprotein defense against circulating endotoxins, protective cytokine profiles, toxin sequestration of fat mass, and antioxidation of muscle may play important roles. Despite claims that obesity paradox is a statistical fallacy and a result of residual confounding, the consistency of data and other causality clues suggest a high biologic plausibility. Examining the causes and consequences of the obesity paradox may help discover important pathophysiologic mechanisms leading to improved outcomes in patients with CKD.
引用
- Kalantar-Zadeh K, Rhee CM, Chou J, et al. The Obesity Paradox in Kidney Disease: How to Reconcile it with Obesity Management. Kidney Int Rep. 2017. PMID: 28439569. doi:10.1016/j.ekir.2017.01.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。